Postbiotic supplement supports canine metabolic health

A peer-reviewed clinical trial published in the journal Animals has demonstrated that supplementation with a postbiotic ingredient can significantly reduce postprandial blood glucose in dogs during a weight-loss programme ‒ a finding with potentially important implications for the management of canine metabolic health.

The study, funded by global nutrition company ADM and conducted at Four Rivers Kennel in Missouri, USA, investigated the effects of Bifidobacterium animalis subspecies lactis CECT 8145 ‒ marketed by ADM as Priome Metabolic Health.

Forty-five adult Labrador Retrievers were enrolled in a randomised, double-blind, placebo-controlled design across two seven-week phases. During each phase, the dogs were divided into three groups: one received the live bacterial supplement (probiotic), another received the heat-treated version (postbiotic), and the third group received a placebo…